SUPER-SOPHISTICATED SCREENING TOOLS

With Quensis, all names are screened automatically while they are created. This means we cut at least one month or more out of the artisanal naming process, by streamlining real time screening, as names are generated.

• No more waiting for batches from name creatives or for legal responses

Trademark Law states that every new brand name must have more than 1 letter and 1 sound of difference from current brand names. Our screening tools meet this demand in real time: we optimize the creative development process by eliminating right away a great deal of bad candidates.

• Our tools not only detect Identical trademarks but also conflicting trademarks with 1 letter difference (wherever the position)
• All names are screened against a set of designated classes and countries, from the key intellectual property registries (WIPO, USPTO, OHIM, national registries of key European countries)

For domain names verifications, not only have we integrated the entire worldwide dotcom database (+80 million) in order to screen names in real time, but we have created a sub-database of 20 million parked sites.

• Quensis gives the guarantee of an available dotcom address if needed

• Quensis also detects parked sites that are potential viable names, for sale, and purchaseable at an affordable price

For the pharmaceutical industry, Quensis has developed tools specifically to meet the needs and constraints imposed by Regulation Authorities: new drug names must be more than 2 letters and 2 sounds of difference from current drug, biologic, molecule or delivery method names.

• Our SIMILAR 2 tools detect conflicting drug names with 2 letters or more of difference, against thousands of existing drug names (sources from regulatory authorities on a country-by-country basis)

• Pharma clients only consider names that are potentially viable, not names they ultimately cannot use

Last, but not least, having access to key Trademark and drug name databases gives us an incredible competitive advantage: linguistic and statistical analysis of trademark and drug names are at the core of Quensis methodology.

• We better guide creative strategy by eliminating dead-ends
• We explore unexpected creative routes
• We expand creative development to the fullest

Save time, money and avoid falling in love with names you cannot have — at last, Quensis has the scientific technique that gets clients to names that are real solutions.